Integrated Radiolabelled Sciences
Pharmaron’s experienced team of synthetic chemists, analytical chemists and drug metabolism scientists synthesize and use Carbon-14 and tritium radiolabelled compounds to study the absorption, distribution, metabolism, excretion (ADME) and fate of a wide variety of compounds in clinical, preclinical and discovery investigations. We offer unrivaled expertise in conducting metabolism and pharmacokinetic studies using radioisotopes.
Radiolabelling and Radiosynthesis
Non-clinical ADME with Radiolabelled Compounds
Human AME with Radiolabelled Compounds
Disposition of Radiolabelled Biologics
Accelerator Mass Spectrometry (AMS)
Request more information about our drug discovery, preclinical and clinical development services